Macrophages as Drivers of Resistance to Dabrafenib Plus Trametinib Therapy in Anaplastic Thyroid Cancer.

Tafinlar (dabrafenib) - Novartis

Mekinist (trametinib) - Novartis, BeOne Medicines

edicotinib (PRV-6527) - Sanofi

http://www.ncbi.nlm.nih.gov/pubmed/42737588

Beatriz Garcia; Branca Maria Cavaco; Miguel Rito; Ricardo Rodrigues; Ruben Roque; Sónia Morgado; Teresa Pereira; Tiago Nunes da Silva; Valeriano Leite; Vanessa Tavares

Sep 16, 2026